This National Institutes of Health (NIH) grant establishes Diversity Centers for Genome Research (DCGR) at Minority Serving Institutions (MSIs). These MSIs must serve historically underrepresented populations, award health-related doctorate degrees, and meet specific NIH funding thresholds. The UG3/UH3 cooperative agreements support developing multi-investigator, interdisciplinary teams. Grantees will establish administrative, genomic workforce development, and community engagement cores, alongside 2-3 innovative genomic research projects. Projects should address critical issues like genomic technology, disease genomics, clinical application, data science, ethical implications, and health equity. A key program goal is to expand the pool of diverse genomic scientists, clinician-scientists, and researchers through didactic and practical experiences aligned with research. This funding prepares institutions for full-scale DCGR operations.
Opportunity ID: 343727
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-HG-22-027 |
Funding Opportunity Title: | Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.172 — Human Genome Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Sep 22, 2022 |
Last Updated Date: | Sep 22, 2022 |
Original Closing Date for Applications: | Jun 24, 2024 |
Current Closing Date for Applications: | Jun 24, 2024 |
Archive Date: | Jul 30, 2024 |
Estimated Total Program Funding: | – |
Award Ceiling: | $300,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | Funding Opportunity PurposeThe full-scale Diversity Centers for Genome Research (DCGR) program aims to establish Genomic Research Centers at Minority Serving Institutions (MSIs) as defined in Part 2, section III of the FOA. The MSIs must have a mission to serve historically underrepresented populations in biomedical research that award doctorate degrees in the health professions or the sciences related to health, and have received an average of less than $50 million per year in NIH support and less than $25 million per year of R01 total cost of NIH support for the past three fiscal years. The purpose of this FOA is to call for applications for UG3/UH3 cooperative agreements to support the development and planning for a multi-investigator, interdisciplinary team to develop administrative, genomic workforce development and community engagement cores and 2-3 interrelated, innovative genomic research projects that address one or more critical issues in genomics including: genomic technology and methods development; genome structure; genome function; genomics of disease; use and impact of genomic information in clinical care; genomic data science and computational genomics, ethical, legal, and social implications of genomic research (ELSI); and/or genomics and health equity. The outcome of the development and feasibility studies will be fully developed plans to carry out all activities of a full-scale Diversity Center for Genome Research. Along with its scientific goals, the DCGR should expand the pool of diverse genomic scientists, clinician scientists, and researchers who can perform innovative genomics research by providing didactic, practicum and research activities and experiences that are aligned with the research projects. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-22-027.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 343727 Full Announcement-RFA-HG-22-027 -> RFA-HG-22-027-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or before January 24, 2023 | PKG00276964 | Nov 04, 2022 | Jan 24, 2023 | View | |
FORMS-H | Do not use. Must use FORMS-H-REVISED form package for all submissions to RFA-HG-22-027 | PKG00278465 | Nov 15, 2022 | Jul 12, 2023 | View | |
FORMS-H-REVISED | This updated form package must be used for all submissions to RFA-HG-22-027.” | PKG00282500 | Jun 24, 2024 | View |
Package 1
Mandatory forms
343727 RR_SF424_5_0-5.0.pdf
343727 PHS398_CoverPageSupplement_5_0-5.0.pdf
343727 RR_OtherProjectInfo_1_4-1.4.pdf
343727 PerformanceSite_4_0-4.0.pdf
343727 RR_KeyPersonExpanded_4_0-4.0.pdf
343727 RR_Budget_3_0-3.0.pdf
343727 PHS398_ResearchPlan_4_0-4.0.pdf
343727 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343727 RR_SubawardBudget30_3_0-3.0.pdf
343727 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
343727 RR_SF424_5_0-5.0.pdf
343727 PHS398_CoverPageSupplement_5_0-5.0.pdf
343727 RR_OtherProjectInfo_1_4-1.4.pdf
343727 PerformanceSite_4_0-4.0.pdf
343727 RR_KeyPersonExpanded_4_0-4.0.pdf
343727 RR_Budget_3_0-3.0.pdf
343727 PHS398_ResearchPlan_5_0-5.0.pdf
343727 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343727 RR_SubawardBudget30_3_0-3.0.pdf
343727 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
343727 RR_SF424_5_0-5.0.pdf
343727 PHS398_CoverPageSupplement_5_0-5.0.pdf
343727 RR_OtherProjectInfo_1_4-1.4.pdf
343727 PerformanceSite_4_0-4.0.pdf
343727 RR_KeyPersonExpanded_4_0-4.0.pdf
343727 RR_Budget10_3_0-3.0.pdf
343727 PHS398_ResearchPlan_5_0-5.0.pdf
343727 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343727 RR_SubawardBudget10_30_3_0-3.0.pdf
343727 PHS_AssignmentRequestForm_3_0-3.0.pdf